Approximately 20–50% of NF-1 patients have osteoporosis, which is associated with alterations in bone transformation biochemical markers, including decreased serum 25-hydroxyvitamin D and elevated serum PTH levels (30). This evidence concerns the gene PTH and osteoporosis.